The Differences Between the Drugs Used in the Pythotrial and the MAPET Trial

When looking at the bleeding risk in the pythotrial study, the risk is proportionately higher than what was studied in the real world./nThe drug studied in the pythotrial was different than the drug studied in the MAPET trial, and tenectiplase is given as a pushdose agent, which may increase the time it takes for the drug to reach its peak effect.